Metabolic Regulation of Redox Balance in Cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Reactive oxygen species (ROS) are crucial signaling molecules that, at high concentrations, can damage DNA and promote cancer initiation.
• Cancer cells often exhibit altered metabolism, leading to increased ROS production and genomic instability, driving tumor evolution.
• While ROS can be oncogenic, cancer cells also activate defense mechanisms to manage oxidative stress.

Purpose of the Study:

• To review the dual role of cellular metabolism in generating and inhibiting ROS in cancer.
• To discuss current therapeutic strategies targeting the ROS axis in tumors.
• To highlight the importance of understanding ROS-regulating metabolic pathways for cancer therapy.

Main Methods:

• Literature review of studies on ROS metabolism in cancer.
• Analysis of signaling pathways involved in ROS production and management.
• Synthesis of information on therapeutic approaches targeting ROS in oncology.

Main Results:

• Metabolism critically influences ROS levels, acting as both a source and a suppressor of oxidative stress in cancer.
• Cancer-associated mutations can dysregulate metabolism, increasing ROS and promoting tumor progression.
• Concurrent activation of ROS-scavenging pathways by cancer cells presents a therapeutic challenge and opportunity.

Conclusions:

• Targeting metabolic pathways that control ROS offers a viable strategy for cancer therapy.
• A comprehensive understanding of the interplay between metabolism and ROS is essential for developing effective anti-cancer treatments.
• Modulating the ROS axis holds potential for selectively eliminating cancer cells while minimizing damage to normal tissues.